Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review
Objective To identify the best evidence on the efficacy of treatment interventions for inclusion body myositis (IBM) and to describe their safety.Methods Systematic review of randomised controlled trials (RCTs) of pharmacological treatments of adults with IBM, conducted according to the Cochrane Han...
Saved in:
| Main Authors: | Pedro M Machado, Eduardo José Ferreira Santos, Nicholas Yapp, Pedro Sousa, Bayram Farisogullari, Hermaleigh Townsley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/11/1/e005176.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01) -
Inclusion-Body Myositis Associated with Alzheimer’s Disease
by: Danijela Levacic, et al.
Published: (2013-01-01) -
Sarcoidosis: Is It a Possible Trigger of Inclusion Body Myositis?
by: Ali Zakaria, et al.
Published: (2017-01-01) -
Inclusion Body Myositis presenting with macroglossia: A diagnostic challenge
by: Aaron Patel, et al.
Published: (2025-06-01) -
Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis
by: Judith Cantó-Santos, et al.
Published: (2025-02-01)